Back to Search Start Over

Supplementary Table S2 from Phase I Study of Rapid Alternation of Sunitinib and Regorafenib for the Treatment of Tyrosine Kinase Inhibitor Refractory Gastrointestinal Stromal Tumors

Details

Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....52c5a6e01b9f814cfb059f296f15d5fe